| Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastasis KL Johung, N Yeh, NB Desai, TM Williams, T Lautenschlaeger, ND Arvold, ... Journal of Clinical Oncology 34 (2), 123-129, 2016 | 346 | 2016 |
| NCCN guidelines insights: Prostate cancer, version 1.2021: Featured updates to the NCCN guidelines E Schaeffer, S Srinivas, ES Antonarakis, AJ Armstrong, JE Bekelman, ... Journal of the National Comprehensive Cancer Network 19 (2), 134-143, 2021 | 341 | 2021 |
| Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies WC Jackson, J Silva, HE Hartman, RT Dess, AU Kishan, WH Beeler, ... International Journal of Radiation Oncology* Biology* Physics 104 (4), 778-789, 2019 | 293 | 2019 |
| Genomic characterization of upper tract urothelial carcinoma JP Sfakianos, EK Cha, G Iyer, SN Scott, EC Zabor, RH Shah, Q Ren, ... European urology 68 (6), 970-977, 2015 | 236 | 2015 |
| Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer HA Al-Ahmadie, G Iyer, BH Lee, SN Scott, R Mehra, A Bagrodia, ... Nature genetics 48 (4), 356-358, 2016 | 177 | 2016 |
| NCCN guidelines® insights: prostate cancer, version 1.2023: featured updates to the NCCN guidelines EM Schaeffer, S Srinivas, N Adra, Y An, D Barocas, R Bitting, A Bryce, ... Journal of the National Comprehensive Cancer Network 20 (12), 1288-1298, 2022 | 135 | 2022 |
| Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers WJ Petty, KH Dragnev, VA Memoli, Y Ma, NB Desai, A Biddle, TH Davis, ... Clinical cancer research 10 (22), 7547-7554, 2004 | 119 | 2004 |
| Small-cell carcinomas of the bladder and lung are characterized by a convergent but distinct pathogenesis MT Chang, A Penson, NB Desai, ND Socci, R Shen, VE Seshan, ... Clinical Cancer Research 24 (8), 1965-1973, 2018 | 96 | 2018 |
| Very early salvage radiotherapy improves distant metastasis-free survival A Abugharib, WC Jackson, V Tumati, RT Dess, JY Lee, SG Zhao, ... The Journal of urology 197 (3 Part 1), 662-668, 2017 | 91 | 2017 |
| The mutational landscape of metastatic castration-sensitive prostate cancer: the spectrum theory revisited MP Deek, K Van der Eecken, R Phillips, NR Parikh, PI Velho, TL Lotan, ... European urology 80 (5), 632-640, 2021 | 76 | 2021 |
| Safety and efficacy of stereotactic ablative radiation therapy for renal cell carcinoma extracranial metastases CJ Wang, A Christie, MH Lin, M Jung, D Weix, L Huelsmann, K Kuhn, ... International Journal of Radiation Oncology* Biology* Physics 98 (1), 91-100, 2017 | 76 | 2017 |
| Specific Chemopreventive Agents Trigger Proteasomal Degradation of G1 Cyclins: Implications for Combination Therapy KH Dragnev, I Pitha-Rowe, Y Ma, WJ Petty, D Sekula, B Murphy, M Rendi, ... Clinical cancer research 10 (7), 2570-2577, 2004 | 72 | 2004 |
| Stereotactic ablative radiation therapy (SAbR) used to defer systemic therapy in oligometastatic renal cell cancer Y Zhang, J Schoenhals, A Christie, O Mohamad, C Wang, I Bowman, ... International Journal of Radiation Oncology* Biology* Physics 105 (2), 367-375, 2019 | 70 | 2019 |
| Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP … NB Desai, NF Stein, MP LaQuaglia, KM Alektiar, BH Kushner, S Modak, ... International Journal of Radiation Oncology* Biology* Physics 85 (1), e67-e72, 2013 | 69 | 2013 |
| Androgen receptor variants mediate DNA repair after prostate cancer irradiation Y Yin, R Li, K Xu, S Ding, J Li, GH Baek, SG Ramanand, S Ding, Z Liu, ... Cancer research 77 (18), 4745-4754, 2017 | 62 | 2017 |
| Bexarotene and erlotinib for aerodigestive tract cancer KH Dragnev, WJ Petty, S Shah, A Biddle, NB Desai, V Memoli, JR Rigas, ... Journal of clinical oncology 23 (34), 8757-8764, 2005 | 62 | 2005 |
| Genomic characterization of response to chemoradiation in urothelial bladder cancer NB Desai, SN Scott, EC Zabor, EK Cha, J Hreiki, JP Sfakianos, R Ramirez, ... Cancer 122 (23), 3715-3723, 2016 | 56 | 2016 |
| A deep learning-based framework for segmenting invisible clinical target volumes with estimated uncertainties for post-operative prostate cancer radiotherapy A Balagopal, D Nguyen, H Morgan, Y Weng, M Dohopolski, MH Lin, ... Medical image analysis 72, 102101, 2021 | 46 | 2021 |
| Magnetic resonance imaging–guided in-bore and magnetic resonance imaging-transrectal ultrasound fusion targeted prostate biopsies: an adjusted comparison of clinically … DN Costa, K Goldberg, AD de Leon, Y Lotan, Y Xi, M Aziz, Y Freifeld, ... European Urology Oncology 2 (4), 397-404, 2019 | 45 | 2019 |
| Intermediate endpoints after postprostatectomy radiotherapy: 5-year distant metastasis to predict overall survival WC Jackson, K Suresh, V Tumati, SG Allen, RT Dess, SS Salami, ... European urology 74 (4), 413-419, 2018 | 39 | 2018 |
